Onco-Innovations Limited (NEO:ONCO)

Onco-Innovations Ratios and Metrics

Market cap in millions CAD. Fiscal year is May - April.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Aug 19, 2026	Apr 30, 2026	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023
Market Capitalization	39	77	76	-	-
Market Cap Growth	-62.24%	1.81%	-	-	-
Enterprise Value	38	77	76	-	-
Last Close Price	0.57	1.30	1.50	-	-
PS Ratio	352.76	701.55	1164.95	-	-
PB Ratio	99.84	198.56	42.13	-	-
P/TBV Ratio	99.84	198.56	42.13	-	-
EV/Sales Ratio	-	696.89	1158.58	-	-
Net Debt / Equity Ratio	-1.99	-1.99	-0.62	-1.40	-1.00
Asset Turnover	0.06	0.06	0.05	-	-
Quick Ratio	0.98	0.98	2.94	3.47	-
Current Ratio	1.46	1.46	5.41	3.47	-
Return on Equity (ROE)	-981.79%	-981.79%	-711.89%	-233.40%	-
Return on Assets (ROA)	-268.33%	-268.33%	-142.42%	-105.54%	-
Return on Capital Employed (ROCE)	-1903.60%	-1903.60%	-168.10%	-123.50%	-1.30%
Earnings Yield	-27.68%	-13.92%	-9.94%	-	-
Buyback Yield / Dilution	-35.96%	-35.96%	-1071.62%	-	-

Data Source: S&P Global Market Intelligence Last updated: Apr 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 17, 2026

Data Sources Report a data error